CH is associated with an increased risk of cardiovascular diseases (5), and CH driven by mutations in one of the most prevalent driver genes, Tet methylcytosine dioxygenase 2 (TET2), is associated with a proinflammatory gene signature in circulating immune cells in both mice and humans (6–8). The gene discussed is TET2; the disease is cardiovascular disorder.